UK – NICE hops on real world data trend to inform guidance

Pharma is reaching a point in time where real world data is invaluable, having already disrupted several working processes.

The National Institute of Health and Care Excellence (NICE) is the latest company to turn to real world data, looking to extend its use to help inform its independent committees who produce its guidance.

The institute already makes use of a wide range of published scientific evidence for its guidance for the NHS on health technologies and its advisory guidelines which demonstrate best practice for diagnosing and managing a range of conditions…